- Home
- Publications
- Publication Search
- Publication Details
Title
Rituximab in paediatric onset multiple sclerosis: a case series
Authors
Keywords
Paediatric onset multiple sclerosis, Observational study, Immunomodulatory treatment, Rituximab
Journal
JOURNAL OF NEUROLOGY
Volume 263, Issue 2, Pages 322-326
Publisher
Springer Nature
Online
2015-11-24
DOI
10.1007/s00415-015-7979-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Swedish MS registry - clinical support tool and scientific resource
- (2015) J. Hillert et al. ACTA NEUROLOGICA SCANDINAVICA
- JC virus antibody status in a pediatric multiple sclerosis cohort: Prevalence, conversion rate and influence on disease severity
- (2014) Peter Huppke et al. Multiple Sclerosis Journal
- Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease
- (2014) R. C. Dale et al. NEUROLOGY
- Rituximab Use in Pediatric Central Demyelinating Disease
- (2014) Shannon J. Beres et al. PEDIATRIC NEUROLOGY
- Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases
- (2013) A Ghezzi et al. Multiple Sclerosis Journal
- Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis
- (2013) Barbara Kornek et al. JAMA Neurology
- Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients
- (2012) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Daclizumab Use in Patients With Pediatric Multiple Sclerosis
- (2012) Mark P. Gorman ARCHIVES OF NEUROLOGY
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Maximally tolerated versus minimally effective dose: the case of rituximab in multiple sclerosis
- (2011) A Scott Nielsen et al. Multiple Sclerosis Journal
- Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis
- (2011) T Chitnis et al. Multiple Sclerosis Journal
- Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial
- (2010) R. T. Naismith et al. NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Increased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple Sclerosis
- (2009) Mark P. Gorman et al. ARCHIVES OF NEUROLOGY
- ‘Rituximab as a highly effective treatment in a female adolescent with severe multiple sclerosis’
- (2009) Michael Karenfort et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
- (2008) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search